Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.
Xiaohui He, Yuan Zhang, Xianyang Luo, Keyi Lu, Shanghua Jing, Zairong Gao, Yali Cui, Zhuming Guo, Zan Shen, Qingjie Ma, Zhongwei Lv, Yong Fang, Linfa Li, Xianhe Xie, Wei Fu, Zhiyong Deng, Lijun Tang, Zhiyong Li, Xingmin Han, Aimin Yang, Bin Liu, Lingling Liu, Liqing Wu, Guihua Wang, Guang Chen, Sha Luan, Shangtong Lei, Yizhuang Cheng, Zhendong Li, Feng Shi, Shukui Qin, Yansong Lin, Yong Ding, Zhendong Chen, Jian Tan, Qinghai Ji, Hui Yang
Clinical cancer research : an official journal of the American Association for Cancer Research 2023;29(15):2791-2799